Advancements in tech, drug discovery, and structural genomics drive growth. Crucial for new therapies and disease treatment solutions. Rising chronic diseases due to poor lifestyles and aging drive growth. Crucial for drug discovery in diabetes, cancer, and heart disease.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Structural Biology Industry Impact
5.2. COVID-19 - Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Structural Biology Market, by Tools
8.1.1. SaaS and Standalone Modeling
8.1.1.1. Market Revenue and Forecast
8.1.2. Visualization and Analysis
8.1.2.1. Market Revenue and Forecast
8.1.3. Others
8.1.3.1. Market Revenue and Forecast
9.1. Structural Biology Market, by Application
9.1.1. Drug Development
9.1.1.1. Market Revenue and Forecast
9.1.2. Drug Discovery
9.1.2.1. Market Revenue and Forecast
9.1.3. Others
9.1.3.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Tools
10.1.2. Market Revenue and Forecast, by Application
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Tools
10.1.3.2. Market Revenue and Forecast, by Application
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Tools
10.1.4.2. Market Revenue and Forecast, by Application
10.2. Europe
10.2.1. Market Revenue and Forecast, by Tools
10.2.2. Market Revenue and Forecast, by Application
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Tools
10.2.3.2. Market Revenue and Forecast, by Application
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Tools
10.2.4.2. Market Revenue and Forecast, by Application
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Tools
10.2.5.2. Market Revenue and Forecast, by Application
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Tools
10.2.6.2. Market Revenue and Forecast, by Application
10.3. APAC
10.3.1. Market Revenue and Forecast, by Tools
10.3.2. Market Revenue and Forecast, by Application
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Tools
10.3.3.2. Market Revenue and Forecast, by Application
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Tools
10.3.4.2. Market Revenue and Forecast, by Application
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Tools
10.3.5.2. Market Revenue and Forecast, by Application
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Tools
10.3.6.2. Market Revenue and Forecast, by Application
10.4. MEA
10.4.1. Market Revenue and Forecast, by Tools
10.4.2. Market Revenue and Forecast, by Application
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Tools
10.4.3.2. Market Revenue and Forecast, by Application
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Tools
10.4.4.2. Market Revenue and Forecast, by Application
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Tools
10.4.5.2. Market Revenue and Forecast, by Application
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Tools
10.4.6.2. Market Revenue and Forecast, by Application
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Tools
10.5.2. Market Revenue and Forecast, by Application
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Tools
10.5.3.2. Market Revenue and Forecast, by Application
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Tools
10.5.4.2. Market Revenue and Forecast, by Application
11.1. BiosolveIT GmbH
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Thermo Fisher Scientific Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Dassault Systemes
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Optibrium Ltd.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Schrodinger
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. OpenEye Scientific Software, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Chemical Computing Group
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Certara, L.P.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Cresset BioMolecular Discovery Ltd.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Acellera Ltd.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample